Sifi Mexico – Juan José Davidovich, General Manager
Juan José Davidovich, general manager of the Italian ophthalmology leader Sifi, speaks about the importance of Mexico as a base to enter Latin America and sets the goal of prospering…
SIFI has made the history of ophthalmology in Italy and has worked in the eye care sector since 1935. Italian market leader for over 15 years, it develops, produces and markets innovative pharmaceutical treatments, tools for diagnosis and surgical devices for prevention and care of the most common ocular pathologies. Since its foundation in 1935, SIFI has displayed a constant commitment to working alongside ophthalmologists. Being close to practitioners, sharing their passion for EyeCare and contributing to the improvement of disease management in ophthalmology is indeed SIFI’s principal concern. The development plans for Latin America has included the constitution in 2007 of a fully owned subsidiary, Laboratorios SIFI de México, which aims to become one of the main players in the local ophthalmic pharmaceutical sector.
Contact details
SIFI de México
Dante 36, Piso 11, Oficina 1101
Col. Anzures, Del. Miguel Hidalgo
CP 11590 México DF
MÉXICO
Tel: +52 (55) 5263 2450
Website: www.sifi.it
Juan José Davidovich, general manager of the Italian ophthalmology leader Sifi, speaks about the importance of Mexico as a base to enter Latin America and sets the goal of prospering…
Can you give us a brief history of the company since your merger in 2003: the main growth drivers, opportunities and challenges? Laboratorios Vanquish was born in 2003, before that…
Please can you give us a brief rundown of the last few years in the Mexican pharmaceutical and how the various regulation changes such as the new drug registration process…
Please can you tell us in your own words how you’ve seen the Mexican pharmaceutical market change over the past five years? Mexico is one of the top ten markets…
You arrived to the position of Boehringer Ingelheim Mexico’s General Director in 2010, what are some of the most exciting milestones and achievements you have presided over during this time?…
Please can you give us a brief rundown of Pierre Fabre’s activities in Mexico since they opened an affiliate here, specifically the company’s milestones and achievements along the way? Pierre…
Since we last spoke to you in 2008, Mexico has undergone a lot of regulatory changes, and we witnessed the rise of Seguro Popular, and the rise of COFEPRIS for…
Grünenthal first started operations in Mexico back in 1998, we then interviewed Mr. Klaus Kuchen in 2005, but we want to know what’s happened since. Please can you give us…
There are about 250 employees and you have regional presence in Latin America. In your view as CEO, can you tell our readers about the biggest growth drivers and challenges…
You came back to Mexico last July- what in your view have been the biggest developments in the Mexican pharmaceutical market since you were last here 11 years ago? The…
Please can you give us a rundown of Shires activities in Mexico in the last four years, and the key achievements and milestones along the way? Shire started operations in…
Please can you give our readers a brief rundown of the major milestones and challenges that you have faced at Octapharma since becoming Managing Director? When Octapharma first came to…
From your perspective in healthcare consultancy at CEGEDIM, what do you think have been the most impactful changes in the Mexican pharmaceutical and healthcare sector over the last few years?…
See our Cookie Privacy Policy Here
